pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,157 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 29 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: filing×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›SUSPENDEDphase readoutNCT03588754: Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

    Sponsor: Yale University. Phase: PHASE2. Conditions: Alcohol Drinking

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06144554: Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

    Sponsor: Insulet Corporation. Phase: . Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01581554: Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05012254: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

    Sponsor: Fundación GECP. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07064005: Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

    Sponsor: Pravat Mandal. Phase: PHASE1. Conditions: Parkinsons Disease (PD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07538505: Testing a Diabetes Care Program in Rural and Low-Income Clinics

    Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00340405: Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Lung Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05924594: Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

    Sponsor: Cingulate Therapeutics. Phase: PHASE3. Conditions: ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyperactivity Disorder Combined, Attention-deficit Hyperactivity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06253494: Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Endometrial Cancer, Cancer of Endometrium, Carcinoma of Endometrium, Endometrial Carcinoma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05736666: Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement

    Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Knee Osteoarthritis, Arthroplasty Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05168566: Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

    Sponsor: Teligene US. Phase: PHASE2. Conditions: Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07239466: A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

    Sponsor: Tao Zhang. Phase: PHASE2. Conditions: Rectal Cancer, Radiotherapy, Immunotherapy, Chemotherapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07529366: Pharmacist-Led Continuous Glucose Monitoring for Prediabetes

    Sponsor: University of South Florida. Phase: . Conditions: Prediabetes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07409766: A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Advanced Malignant Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07355322: Comparison of a 3-step Bonding System (Transbond™ XT) and a 2-step System (GC Ortho Connect™) on Demineralization Around Maxillary Orthodontic Brackets

    Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Tooth Demineralization, White Spot Lesion, Demineralization, Orthodontic Appliance Complication, Dental Braces Complication

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06260722: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07343622: Robot/Laparoscopic-Assisted Transanal Transection Duhamel Versus Modified Soave Pull-Through for TCA

    Sponsor: Zunyi Medical College. Phase: NA. Conditions: Total Colonic Aganglionosis, Hirschsprung Disease, Duhamel, Soave

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07446751: Long-term Outcomes of SMILE PRO for High Astigmatism

    Sponsor: Hanoi Medical University. Phase: NA. Conditions: High Astigmatism

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05972551: Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

    Sponsor: Amgen. Phase: PHASE3. Conditions: Osteogenesis Imperfecta

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03726151: Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs

    Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Human Papillomavirus Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07523451: COMPARISON BETWEEN DIFFERENT CONCENTRATIONS OF OZONE GAS AS AN INTRA-ARTICULAR INJECTION FOR TREATMENT OF INTERNAL DERANGEMENT OF TEMPROMANDIBULAR JOINT

    Sponsor: Alexandria University. Phase: NA. Conditions: TMJ Disc Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05587751: Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Hormonal Gender-Affirming Therapy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07531251: Clinical Trial in Patients With Barth Syndrome- 4TAZPower

    Sponsor: Stealth BioTherapeutics Inc.. Phase: PHASE4. Conditions: Barth Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04410796: Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Metastatic Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06874296: Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time

    Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Liver Transplantation, Liver Diseases, Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03743662: Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Glioblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05183646: A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

    Sponsor: Dimerix Bioscience Pty Ltd. Phase: PHASE3. Conditions: FSGS

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07357688: The Effect of Acupuncture Therapy on Cognitive Function in Post-COVID-19 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Sponsor: Xi Wu. Phase: NA. Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07326488: A Study of MHB009C in Patients With Advanced Solid Tumors

    Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd. Phase: PHASE1. Conditions: Advanced Malignant Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03115203: Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Facial Paralysis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05436327: Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer, Aging, Communication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07392827: Pediatric Postoperative Pain Management

    Sponsor: Hacettepe University. Phase: . Conditions: Postoperative Pain, Pediatric Anesthesia Department, Regional Anaesthesia, Pain Scale, Caudal Epidural Anesthesia, Pediatric Surgical Patients

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02598661: Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

    Sponsor: Geron Corporation. Phase: PHASE2. Conditions: Myelodysplastic Syndromes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05677308: LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

    Sponsor: AstraZeneca. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05945576: IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Silver Russell Syndrome, Beckwith-Wiedemann Syndrome, Transient Neonatal Diabetes Mellitus, Angelman Syndrome, Prader-Willi Syndrome, Temple Syndrome, Kagami-Ogata Syndrome, Pseudohypoparathyroidism, Familial Precocious Puberty

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07356817: Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

    Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Phase: . Conditions: Cardiovascular (CV) Risk, Preeclampsia (PE), Fetal Weight

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03229317: Respiratory Outcome of Children From the FEPED Cohort

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Asthma in Children

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03372317: Tau PET in Imaging and Cognition: Healthy Adults From 55-90

    Sponsor: Yaakov Stern. Phase: . Conditions: Mild Cognitive Impairment, Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05972317: The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients

    Sponsor: Weizmann Institute of Science. Phase: NA. Conditions: Irritable Bowel Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07411040: Effects of Body Awareness Therapy on Physical and Psychosocial Outcomes in Adults With Asthma

    Sponsor: Recep Tayyip Erdogan University. Phase: NA. Conditions: Asthma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07566689: Holmium Laser Enucleation Of the Prostate Versus Water Vapor Therapy Of The Prostate on Sexual Function and Ejaculation

    Sponsor: Beni-Suef University. Phase: NA. Conditions: Benign Prostate Hypertrophy(BPH)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07340489: Serplulimab for Locally Advanced Cervical Cancer

    Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Cervical Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06074068: Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

    Sponsor: Yale University. Phase: NA. Conditions: Intimate Partner Violence, Child Maltreatment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07224191: Hippocampal Oscillations During Exploration

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Epilepsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07145190: SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

    Sponsor: Bial - Portela C S.A.. Phase: . Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03387774: Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

    Sponsor: Sun Yat-sen University. Phase: PHASE3. Conditions: Oral Mucositis (Ulcerative) Due to Radiation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06486974: Efficacy of Manual Toothbrushes in Removing Tooth Stains

    Sponsor: Colgate Palmolive. Phase: PHASE3. Conditions: Tooth Discoloration

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06680518: Tourniquet Use in Hallux Valgus Surgery

    Sponsor: Clinique Saint Jean, France. Phase: NA. Conditions: Hallux Valgus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07559890: Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain

    Sponsor: EPC Education s.r.o.. Phase: NA. Conditions: Chronic Back Pain, Basivertebral Nerve Ablation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07507513: The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

    Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.. Phase: PHASE2. Conditions: Ulcerative Colitis (UC)

    full page →ctgov ↗
    ← prev
    page 67 of 104
    next →